Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

PHASE4CompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

August 31, 2005

Conditions
Colorectal Neoplasms
Interventions
PROCEDURE

Blood draw

Trial Locations (34)

11570

Pfizer Investigational Site, Rockville Centre

20007

Pfizer Investigational Site, Washington D.C.

21401

Pfizer Investigational Site, Annapolis

23606

Pfizer Investigational Site, Newport News

27157

Pfizer Investigational Site, Winston-Salem

27834

Pfizer Investigational Site, Greenville

28602

Pfizer Investigational Site, Hickory

28738

Pfizer Investigational Site, Hendersonville

29406

Pfizer Investigational Site, Charleston

32207

Pfizer Investigational Site, Jacksonville

33321

Pfizer Investigational Site, Tamarac

34652

Pfizer Investigational Site, New Port Richey

36608

Pfizer Investigational Site, Mobile

43701

Pfizer Investigational Site, Zanesville

47802

Pfizer Investigational Site, Terre Haute

53226

Pfizer Investigational Site, Milwaukee

55422

Pfizer Investigational Site, Minneapolis

59101

Pfizer Investigational Site, Billings

65212

Pfizer Investigational Site, Columbia

70115

Pfizer Investigational Site, New Orleans

76508

Pfizer Investigational Site, Temple

85715

Pfizer Investigational Site, Tucson

89106

Pfizer Investigational Site, Las Vegas

93710

Pfizer Investigational Site, Fresno

06902

Pfizer Investigational Site, Stamford

61108-2472

Pfizer Investigational Site, Rockford

01201

Pfizer Investigational Site, Pittsfield

03106

Pfizer Investigational Site, Hooksett

03756

Pfizer Investigational Site, Lebanon

B3H 2E2

Pfizer Investigational Site, Halifax

K7L 5P9

Pfizer Investigational Site, Kingston

N2G 1G3

Pfizer Investigational Site, Kitchener

Unknown

Pfizer Investigational Site, Windsor

J1H 5N4

Pfizer Investigational Site, Fleurimont

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY